Heparin-Mediated Conformational Changes in Fibronectin Expose Vascular Endothelial Growth Factor Binding Sites

Maria Mitsi, Zhenning Hong, Catherine E. Costello, and Matthew A. Nugent*§
Departments of Biochemistry and Ophthalmology, Boston University School of Medicine, Boston, Massachusetts 02118, and Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Biochemistry, 2006, 45 (34), pp 10319–10328
DOI: 10.1021/bi060974p
Publication Date (Web): August 8, 2006
Copyright © 2006 American Chemical Society

 Supported by NIH Grants HL56200 and HL46902 to M.A.N. and RR10888 to C.E.C. and by a departmental grant from the Massachusetts Lions Eye Research Fund, Inc.

,

 Department of Biochemistry, Boston University School of Medicine.

,
*

 To whom correspondence should be addressed at the Department of Biochemistry, Boston University School of Medicine. Tel:  617-638-4169. Fax:  617-638-5339. E-mail:  mnugent@bu.edu.

,
§

 Department of Ophthalmology, Boston University School of Medicine.

,

 Department of Biomedical Engineering, Boston University.

Abstract

Abstract Image

Regulation of angiogenesis involves interactions between vascular endothelial growth factor (VEGF) and components of the extracellular matrix, including fibronectin and heparan sulfate. In the present study, we identified two classes of VEGF binding sites on fibronectin. One was constitutively available whereas the availability of the other was modulated by the conformational state of fibronectin. Atomic force microscopy studies revealed that heparin and hydrophilic substrates promoted the extended conformation of fibronectin, leading to increased VEGF binding. The ability of heparin to enhance VEGF binding to fibronectin was dependent on the chemical composition and chain length of heparin, since long (>22 saccharides) heparin chains with sulfation on the 6-O and N positions of glucosamine units were required for full activity. Treatment of the complex endothelial extracellular matrix with heparin also increased VEGF binding, suggesting that heparin/heparan sulfate might regulate VEGF interactions within the extracellular matrix by controlling the structure and organization of fibronectin matrices.

Tools

History

  • Published In Issue August 29, 2006
  • Received May 17, 2006
    Revised Manuscript Received June 28, 2006

Recommend & Share

Related Content

Other ACS content by these authors: